Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZURNAI™ safely and effectively. See full prescribing information for ZURNAI. ZURNAI (nalmefene injection), for intramuscular or subcutaneous use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
ZURNAI is indicated for the emergency treatment of known or suspected opioid overdose induced by natural or synthetic opioids in adults and pediatric patients aged 12 years and older, as manifested by respiratory and/or central nervous system depression. ZURNAI is intended for immediate administration as emergency therapy in settings where opioids may be present. ZURNAI is not a substitute for emergency medical care.
- generic_name
- nalmefene hydrochloride
- product_names
- NALMEFENE HYDROCHLORIDE
- ndc
- 59011-962, 59011-962-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en